Geneva and Monthey: Februrary 11, 2020 – CSG-BIO SA (CSG-Bio), which intends to offer the most advancedand comprehensive stem cell banking services to families worldwide in the near future and took over some of CryoSave AG’s assets in 2019 has now announced the signing of an agreement with CORDSAVINGS SA (CordSavings), the reputed independent Swiss neonatal stem cells laboratory, in the aim to secure part of stem cell samples left in insecurity following the bankruptcy of the Swiss company Cryo-Save AG in September 2019.
The full press release’s version in English